-
1
-
-
34249291096
-
The tumor suppressor PP2A Aβ regulates the RalA GTPase
-
DOI 10.1016/j.cell.2007.03.047, PII S0092867407005168
-
Sablina AA, et al. The tumor suppressor PP2A Ab regulates the RalA GTPase. Cell. 2007;129:969-82. (Pubitemid 46813152)
-
(2007)
Cell
, vol.129
, Issue.5
, pp. 969-982
-
-
Sablina, A.A.1
Chen, W.2
Arroyo, J.D.3
Corral, L.4
Hector, M.5
Bulmer, S.E.6
DeCaprio, J.A.7
Hahn, W.C.8
-
2
-
-
0034708257
-
Low frequency of alterations of the α (PPP2R1A) and β (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms
-
Calin GA, et al. Low frequency of alterations of the a (PPP2R1A) and b (PPP2R1B) isoforms of the subunit A of the serine-thre-onine phosphatase 2A in human neoplasms. Oncogene. 2000;19: 1191-5. (Pubitemid 30157549)
-
(2000)
Oncogene
, vol.19
, Issue.9
, pp. 1191-1195
-
-
Calin, G.A.1
Di Iasio, M.G.2
Caprini, E.3
Vorechovsky, I.4
Natali, P.G.5
Sozzi, G.6
Croce, C.M.7
Barbanti-Brodano, G.8
Russo, G.9
Negrini, M.10
-
3
-
-
41849140001
-
Mechanisms of MYC stabilization in human malignancies
-
Junttila MR, Westermarck J. Mechanisms of MYC stabilization in human malignancies. Cell Cycle. 2008;7:592-6. (Pubitemid 351498996)
-
(2008)
Cell Cycle
, vol.7
, Issue.5
, pp. 592-596
-
-
Junttila, M.R.1
Westermarck, J.2
-
4
-
-
2342526543
-
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells
-
DOI 10.1038/ncb1110
-
Yeh E, et al. A signaling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol. 2004;6:308-18. (Pubitemid 38584820)
-
(2004)
Nature Cell Biology
, vol.6
, Issue.4
, pp. 308-318
-
-
Yeh, E.1
Cunningham, M.2
Arnold, H.3
Chasse, D.4
Monteith, T.5
Ivaldi, G.6
Hahn, W.C.7
Stukenberg, P.T.8
Shenolikar, S.9
Uchida, T.10
Counter, C.M.11
Nevins, J.R.12
Means, A.R.13
Sears, R.14
-
5
-
-
34447283580
-
CIP2A inhibits PP2A in human malignancies
-
DOI 10.1016/j.cell.2007.04.044, PII S0092867407006666
-
Junttila MR, et al. CIP2A inhibits PP2A in human malignancies. Cell. 2007;130:51-62. (Pubitemid 47039258)
-
(2007)
Cell
, vol.130
, Issue.1
, pp. 51-62
-
-
Junttila, M.R.1
Puustinen, P.2
Niemela, M.3
Ahola, R.4
Arnold, H.5
Bottzauw, T.6
Ala-aho, R.7
Nielsen, C.8
Ivaska, J.9
Taya, Y.10
Lu, S.-L.11
Lin, S.12
Chan, E.K.L.13
Wang, X.-J.14
Grenman, R.15
Kast, J.16
Kallunki, T.17
Sears, R.18
Kahari, V.-M.19
Westermarck, J.20
more..
-
6
-
-
52449121851
-
Cip2a is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells
-
Li W, Ge Z, Liu C, et al. CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells. Clin Cancer Res. 2008;14:3722-8.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 3722-3728
-
-
Li, W.1
Ge, Z.2
Liu, C.3
-
7
-
-
0035983640
-
Chemoradiotherapy of esophageal cancer
-
Albertsson M. Chemoradiotherapy of esophageal cancer. Acta Oncol. 2002;41:118-23.
-
(2002)
Acta Oncol
, vol.41
, pp. 118-123
-
-
Albertsson, M.1
-
8
-
-
33947611435
-
Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma
-
DOI 10.1200/JCO.2006.08.0283
-
Izzo JG, et al. Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adeno-carcinoma. J Clin Oncol. 2007;25:698-707. (Pubitemid 350002926)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.6
, pp. 698-707
-
-
Izzo, J.G.1
Wu, T.-T.2
Wu, X.3
Ensor, J.4
Luthra, R.5
Pan, J.6
Correa, A.7
Swisher, S.G.8
Chao, C.K.S.9
Hittelman, W.N.10
Ajani, J.A.11
-
9
-
-
14844322405
-
waf, mdm2, C-erbB2 and impact on survival
-
DOI 10.1111/j.1440-1827.2005.01804.x
-
Bahnassy AA, Zekri AR, Abdallah S, El-Shehaby AM, Sherif GM. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival. Pathol Int. 2005;55:53-62. (Pubitemid 40343724)
-
(2005)
Pathology International
, vol.55
, Issue.2
, pp. 53-62
-
-
Bahnassy, A.A.1
Zekri, A.-R.N.2
Abdallah, S.3
El-Shehaby, A.M.R.4
Sherif, G.M.5
-
10
-
-
0027983696
-
Analysis of gene amplification and overexpression in human esophageal-carcinoma cell lines
-
DOI 10.1002/ijc.2910580224
-
Kanda Y, et al. Analysis of gene amplification and overexpres-sion in human esophageal-carcinoma cell lines. Int J Cancer. 1994;58:291-7. (Pubitemid 24240110)
-
(1994)
International Journal of Cancer
, vol.58
, Issue.2
, pp. 291-297
-
-
Kanda, Y.1
Nishiyama, Y.2
Shimada, Y.3
Imamura, M.4
Nomura, H.5
Hia, H.6
Fukumoto, M.7
-
11
-
-
0029047362
-
A biomarker that identifies senescent human cells in culture and in aging skin in vivo
-
Dimri GP, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 1995;92:9363-7.
-
(1995)
Proc Natl Acad Sci USA.
, vol.92
, pp. 9363-9367
-
-
Dimri, G.P.1
-
12
-
-
67449085399
-
Myc-dependent regulation and prognostic role of cip2a in gastric cancer
-
Khanna A, et al. MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. J Natl Cancer Inst. 2009;101: 793-805.
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 793-805
-
-
Khanna, A.1
-
13
-
-
0035957406
-
Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells
-
DOI 10.1073/pnas.071043198
-
Xu D, et al. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse trans-criptase promoter during differentiation of HL60 cells. Proc Natl Acad Sci USA. 2001;98:3826-31. (Pubitemid 32249856)
-
(2001)
Proceedings of the National Academy of Sciences of the United States of America
, vol.98
, Issue.7
, pp. 3826-3831
-
-
Xu, D.1
Popov, N.2
Hou, M.3
Wang, Q.4
Bjorkholm, M.5
Gruber, A.6
Menkel, A.R.7
Henriksson, M.8
-
14
-
-
69349102025
-
Cip2a is associated with human breast cancer aggressivity
-
Côme C, et al. CIP2A is associated with human breast cancer aggressivity. Clin Cancer Res. 2009;15:5092-100.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 5092-5100
-
-
Côme, C.1
-
15
-
-
27944448894
-
Involvement of PP2A in viral and cellular transformation
-
DOI 10.1038/sj.onc.1209038, PII 1209038
-
Arroyo JD, Hahn WC. Involvement of PP2A in viral and cellular transformation. Oncogene. 2005;24:7746-55. (Pubitemid 41670676)
-
(2005)
Oncogene
, vol.24
, Issue.52
, pp. 7746-7755
-
-
Arroyo, J.D.1
Hahn, W.C.2
-
16
-
-
9244224723
-
Intrinsic tumour suppression
-
DOI 10.1038/nature03098
-
Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature. 2004;432:307-15. (Pubitemid 39551658)
-
(2004)
Nature
, vol.432
, Issue.7015
, pp. 307-315
-
-
Lowe, S.W.1
Cepero, E.2
Evan, G.3
-
17
-
-
23244461708
-
Oncogene-induced senescence as an initial barrier in lymphoma development
-
DOI 10.1038/nature03841
-
Braig M, et al. Oncogene induced senescence as an initial barrier in lymphoma development. Nature. 2005;436:660-5. (Pubitemid 41117262)
-
(2005)
Nature
, vol.436
, Issue.7051
, pp. 660-665
-
-
Braig, M.1
Lee, S.2
Loddenkemper, C.3
Rudolph, C.4
Peters, A.H.F.M.5
Schlegelberger, B.6
Stein, H.7
Dorken, B.8
Jenuwein, T.9
Schmitt, C.A.10
-
18
-
-
23244460597
-
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
-
DOI 10.1038/nature03918
-
Chen Z, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature. 2005;436: 725-30. (Pubitemid 41117277)
-
(2005)
Nature
, vol.436
, Issue.7051
, pp. 725-730
-
-
Chen, Z.1
Trotman, L.C.2
Shaffer, D.3
Lin, H.-K.4
Dotan, Z.A.5
Niki, M.6
Koutcher, J.A.7
Scher, H.I.8
Ludwig, T.9
Gerald, W.10
Cordon-Cardo, C.11
Pandolfi, P.P.12
|